Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Posts 10-Percent Rise in Q1 Revenues as Bio-Analytical Segment Grows 6 Percent

NEW YORK, Feb. 13 (GenomeWeb News) - Agilent Technologies today reported a 10-percent rise in first-quarter revenues as orders in its Bio-Analytical Measurement segment rose 6 percent.


The company's total revenues in the quarter ended Dec. 31, 2005, increased to $1.34 billion from $1.21 billion in the year-ago period. Revenues from the Bio-Analytical Measurement segment climbed 5 percent to $373 million from $354 million, while orders rose to $378 million in the quarter from $356 million a year earlier.


Agilent's research and development spending in the first quarter rose to $189 million from $175 million in the year-ago quarter.


The company's first-quarter adjusted net income jumped to $154 million, or $.32 per share, from $71 million, or $.15 per share, the year before. These numbrs excluded charges related to the planned spin off of Agilent's Semiconductor Test Solutions unit and the reduction in infrastructure costs, as well as related non-cash stock compensation expenses.


As of Jan. 31, Agilent had cash and cash equivalents totaling $2.7 billion.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.